Adial (ADIL) news
Recent news
Adial Pharmaceuticals Inc: Alliance Global Partners initiates coverage with buy rating; price target $11
AInvest Wire · Aug 3, 2026Coastlands Capital LP reports 9.98% passive stake in Adial Pharmaceuticals as of June 17 - SEC filing
Coastlands Capital LP has disclosed a 9.98% passive stake in Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) as of June 17, 2026, according to a recent SEC filing. The investment is part of a broader $64 million private placement financing led by Coastlands, which includes both an initial $32 million…
AInvest Wire · Jun 24, 2026Adial: potential to get added $32M under added milestones
AInvest Wire · Jun 11, 2026Adial: $32M in upfront financing
AInvest Wire · Jun 11, 2026Adial Pharmaceuticals - post-deal: Adial holders 7.7%, Azora holders 51%, investors 41.3% of common stock
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) has completed a 1-for-25 reverse stock split, effective February 5, 2026, to regain Nasdaq compliance . The move reduced outstanding shares to 1.1 million , while maintaining proportional ownership for shareholders. The stock began trading on a…
AInvest Wire · Jun 11, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.